Valuation: DexCom, Inc.

Market Cap 33.49B 570B 28.92B 27.13B 24.71B 46.46B 3,203B 47.1B 318B 125B 1,604B 126B 123B 5,337B P/E 2026 *
35.6x
P/E 2027 * 29.9x
Enterprise Value 32.73B 557B 28.26B 26.51B 24.15B 45.4B 3,130B 46.03B 311B 122B 1,568B 123B 120B 5,216B EV / Sales 2026 *
6.26x
EV / Sales 2027 * 5.59x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-1.10%
1 week+1.89%
Current month+6.85%
1 month+12.52%
3 months+43.52%
6 months+27.33%
Current year+25.97%
1 week 1,528
Extreme 1528
1,544.99
1 month 1,235
Extreme 1235
1,544.99
Current year 1,064.65
Extreme 1064.65
1,544.99
1 year 1,062.55
Extreme 1062.55
1,581
3 years 1,062.55
Extreme 1062.55
2,260
5 years 1,062.55
Extreme 1062.55
3,366.38
10 years 212.78
Extreme 212.775
3,366.38
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%+1.89% - - 33.49B
-0.79%+1.61%-16.23%+5.18% 191B
-0.73%+1.33%-2.60%+11.08% 116B
-0.41%-3.84%+6.73%+73.62% 59.64B
-0.42%+1.08%+34.00%+70.00% 55.42B
-0.71%+1.37%-7.07%-33.92% 49.6B
-1.10%+1.27%+9.65%-17.67% 33.49B
-2.41%+3.16% - - 30.6B
-1.60%-0.79%-7.55%+24.99% 24.25B
-0.80%-1.57%+40.78%-11.77% 24.39B
Average -1.01%+0.63%+7.21%+15.19% 64.93B
Weighted average by Cap. -0.85%+0.81%-0.60%+15.51%

Financials

2026 *2027 *
Net sales 5.23B 89.03B 4.52B 4.24B 3.86B 7.25B 500B 7.35B 49.66B 19.46B 251B 19.64B 19.21B 833B 5.8B 98.72B 5.01B 4.7B 4.28B 8.04B 555B 8.16B 55.06B 21.58B 278B 21.77B 21.3B 924B
Net income 974M 16.59B 841M 789M 719M 1.35B 93.16B 1.37B 9.25B 3.63B 46.67B 3.66B 3.58B 155B 1.15B 19.56B 992M 931M 848M 1.59B 110B 1.62B 10.91B 4.27B 55.04B 4.31B 4.22B 183B
Net Debt -761M -12.96B -657M -616M -561M -1.06B -72.78B -1.07B -7.23B -2.83B -36.46B -2.86B -2.8B -121B -1.06B -18.07B -916M -860M -783M -1.47B -101B -1.49B -10.08B -3.95B -50.85B -3.99B -3.9B -169B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
14/08/26 MXN 1,528.00 -1.10% 325
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
88.76USD
Average target price
94.12USD
Spread / Average Target
+6.04%

Quarterly revenue - Rate of surprise